Metagenomic Next-Generation Sequencing of the 2014 Ebola Virus Disease Outbreak in the Democratic Republic of the Congo.


Journal

Journal of clinical microbiology
ISSN: 1098-660X
Titre abrégé: J Clin Microbiol
Pays: United States
ID NLM: 7505564

Informations de publication

Date de publication:
09 2019
Historique:
received: 22 05 2019
accepted: 26 06 2019
pubmed: 19 7 2019
medline: 8 7 2020
entrez: 19 7 2019
Statut: epublish

Résumé

We applied metagenomic next-generation sequencing (mNGS) to detect Zaire Ebola virus (EBOV) and other potential pathogens from whole-blood samples from 70 patients with suspected Ebola hemorrhagic fever during a 2014 outbreak in Boende, Democratic Republic of the Congo (DRC) and correlated these findings with clinical symptoms. Twenty of 31 patients (64.5%) tested in Kinshasa, DRC, were EBOV positive by quantitative reverse transcriptase PCR (qRT-PCR). Despite partial degradation of sample RNA during shipping and handling, mNGS followed by EBOV-specific capture probe enrichment in a U.S. genomics laboratory identified EBOV reads in 22 of 70 samples (31.4%) versus in 21 of 70 (30.0%) EBOV-positive samples by repeat qRT-PCR (overall concordance = 87.1%). Reads from

Identifiants

pubmed: 31315955
pii: JCM.00827-19
doi: 10.1128/JCM.00827-19
pmc: PMC6711896
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : R01 HL105704
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI120977
Pays : United States
Organisme : NIAID NIH HHS
ID : R33 AI120977
Pays : United States

Informations de copyright

Copyright © 2019 Li et al.

Références

Lancet Infect Dis. 2003 May;3(5):271
pubmed: 12726972
Syst Biol. 2003 Oct;52(5):696-704
pubmed: 14530136
Nucleic Acids Res. 2005 Jan 20;33(2):511-8
pubmed: 15661851
Nature. 2005 Dec 1;438(7068):575-6
pubmed: 16319873
BMC Evol Biol. 2007 Nov 08;7:214
pubmed: 17996036
Am J Trop Med Hyg. 2010 May;82(5):954-60
pubmed: 20439981
PLoS One. 2010 Oct 18;5(10):e13381
pubmed: 20976137
Bioinformatics. 2012 Jun 15;28(12):1647-9
pubmed: 22543367
PLoS One. 2012;7(6):e38499
pubmed: 22723863
Nat Methods. 2012 Jul 30;9(8):772
pubmed: 22847109
Zoonoses Public Health. 2012 Sep;59 Suppl 2:151-7
pubmed: 22958259
Bioinformatics. 2014 May 1;30(9):1312-3
pubmed: 24451623
Genome Res. 2014 Jul;24(7):1180-92
pubmed: 24899342
MBio. 2014 Jun 17;5(3):e01360-14
pubmed: 24939889
N Engl J Med. 2014 Oct 16;371(16):1481-95
pubmed: 25244186
N Engl J Med. 2014 Nov 27;371(22):2083-91
pubmed: 25317743
PLoS Biol. 2015 Jan 21;13(1):e1002057
pubmed: 25607595
Lancet Infect Dis. 2015 Jun;15(6):671-82
pubmed: 25837569
Lancet Infect Dis. 2015 Jul;15(7):825-32
pubmed: 25921597
J Virol. 2015 Oct;89(19):10130-2
pubmed: 26202242
Infect Dis Ther. 2015 Dec;4(4):365-90
pubmed: 26363787
Genome Med. 2015 Sep 29;7:99
pubmed: 26416663
PLoS One. 2015 Nov 23;10(11):e0141723
pubmed: 26599538
Emerg Infect Dis. 2016 Feb;22(2):323-6
pubmed: 26814608
Nature. 2016 Feb 11;530(7589):228-232
pubmed: 26840485
J Clin Microbiol. 2016 Sep;54(9):2348-53
pubmed: 27413190
Emerg Infect Dis. 2016 Oct;22(10):1788-92
pubmed: 27448188
Nature. 2016 Oct 12;538(7624):193-200
pubmed: 27734858
Virus Evol. 2016 Apr 09;2(1):vew007
pubmed: 27774300
Annu Rev Pathol. 2017 Jan 24;12:387-418
pubmed: 27959626
Lancet Infect Dis. 2017 Jun;17(6):654-660
pubmed: 28258817
Clin Infect Dis. 2017 Oct 16;65(9):1477-1485
pubmed: 29020199
J Crit Care. 2017 Dec;42:366-372
pubmed: 29128377
Vet Sci. 2018 Feb 06;5(1):null
pubmed: 29415432
JAMA. 2018 May 1;319(17):1802-1813
pubmed: 29715359
Cell Host Microbe. 2018 Jun 13;23(6):855-864.e7
pubmed: 29805095
Clin Pediatr (Phila). 1972 May;11(5):272-6
pubmed: 4337632

Auteurs

Tony Li (T)

Department of Laboratory Medicine, University of California, San Francisco, San Francisco, California, USA.
UCSF-Abbott Viral Diagnostics and Discovery Center, University of California, San Francisco, San Francisco, California, USA.

Placide Mbala-Kingebeni (P)

Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo.

Samia N Naccache (SN)

Department of Laboratory Medicine, University of California, San Francisco, San Francisco, California, USA.
UCSF-Abbott Viral Diagnostics and Discovery Center, University of California, San Francisco, San Francisco, California, USA.

Julien Thézé (J)

Department of Zoology, University of Oxford, Oxford, United Kingdom.

Jerome Bouquet (J)

Department of Laboratory Medicine, University of California, San Francisco, San Francisco, California, USA.
UCSF-Abbott Viral Diagnostics and Discovery Center, University of California, San Francisco, San Francisco, California, USA.

Scot Federman (S)

Department of Laboratory Medicine, University of California, San Francisco, San Francisco, California, USA.
UCSF-Abbott Viral Diagnostics and Discovery Center, University of California, San Francisco, San Francisco, California, USA.

Sneha Somasekar (S)

Department of Laboratory Medicine, University of California, San Francisco, San Francisco, California, USA.
UCSF-Abbott Viral Diagnostics and Discovery Center, University of California, San Francisco, San Francisco, California, USA.

Guixia Yu (G)

Department of Laboratory Medicine, University of California, San Francisco, San Francisco, California, USA.
UCSF-Abbott Viral Diagnostics and Discovery Center, University of California, San Francisco, San Francisco, California, USA.

Claudia Sanchez-San Martin (C)

Department of Laboratory Medicine, University of California, San Francisco, San Francisco, California, USA.
UCSF-Abbott Viral Diagnostics and Discovery Center, University of California, San Francisco, San Francisco, California, USA.

Asmeeta Achari (A)

Department of Laboratory Medicine, University of California, San Francisco, San Francisco, California, USA.
UCSF-Abbott Viral Diagnostics and Discovery Center, University of California, San Francisco, San Francisco, California, USA.

Bradley S Schneider (BS)

Etiologic, Inc., San Francisco, California, USA.

Anne W Rimoin (AW)

Department of Epidemiology, School of Public Health, University of California, Los Angeles, Los Angeles, California, USA.

Andrew Rambaut (A)

Institute of Evolutionary Biology, University of Edinburgh, Edinburgh, United Kingdom.

Justus Nsio (J)

Ministry of Public Health, Kinshasa, Democratic Republic of the Congo.

Prime Mulembakani (P)

Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo.

Steve Ahuka-Mundeke (S)

Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo.

Jimmy Kapetshi (J)

Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo.

Oliver G Pybus (OG)

Department of Zoology, University of Oxford, Oxford, United Kingdom.

Jean-Jacques Muyembe-Tamfum (JJ)

Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo.

Charles Y Chiu (CY)

Department of Laboratory Medicine, University of California, San Francisco, San Francisco, California, USA Charles.chiu@ucsf.edu.
UCSF-Abbott Viral Diagnostics and Discovery Center, University of California, San Francisco, San Francisco, California, USA.
Department of Medicine, Division of Infectious Diseases, University of California, San Francisco, San Francisco, California, USA.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH